195 related articles for article (PubMed ID: 24304617)
41. The role of microRNA-200 in progression of human colorectal and breast cancer.
Bojmar L; Karlsson E; Ellegård S; Olsson H; Björnsson B; Hallböök O; Larsson M; Stål O; Sandström P
PLoS One; 2013; 8(12):e84815. PubMed ID: 24376848
[TBL] [Abstract][Full Text] [Related]
42. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
[TBL] [Abstract][Full Text] [Related]
43. Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression.
Huang MT; Wei PL; Liu JJ; Liu DZ; Huey-Chun H; An J; Wu CC; Wu CH; Ho YS; Yang YY; Chang YJ
Ann Surg Oncol; 2010 Dec; 17(12):3379-85. PubMed ID: 20625840
[TBL] [Abstract][Full Text] [Related]
44. [Expression of sal-like 4 in primary hepatocellular carcinoma and its association with epithelial-mesenchymal transition].
Xu J; Wang J; Hu Y; Wang XX; Cheng LL; Yu HY
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):500-505. PubMed ID: 27784427
[No Abstract] [Full Text] [Related]
45. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.
Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C
BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980
[TBL] [Abstract][Full Text] [Related]
46. Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition.
Kakihana M; Ohira T; Chan D; Webster RB; Kato H; Drabkin HA; Gemmill RM
J Thorac Oncol; 2009 Dec; 4(12):1455-65. PubMed ID: 20009910
[TBL] [Abstract][Full Text] [Related]
47. Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy.
Zhang D; Cao L; Li Y; Lu H; Yang X; Xue P
World J Surg Oncol; 2013 Jan; 11():25. PubMed ID: 23356443
[TBL] [Abstract][Full Text] [Related]
48. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
Xie C; Wu J; Yun J; Lai J; Yuan Y; Gao Z; Li M; Li J; Song L
PLoS One; 2013; 8(5):e64235. PubMed ID: 23717574
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.
Liu Y; Jiang P; Wang G; Liu X; Luo S
Eur J Surg Oncol; 2018 Jul; 44(7):1087-1093. PubMed ID: 29764705
[TBL] [Abstract][Full Text] [Related]
50. Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhang W; Lui EL; Zhu Y; Lu P; Yu X; Sun J; Yang S; Poon RT; Fan ST
Int J Cancer; 2012 Aug; 131(3):E163-72. PubMed ID: 22052196
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathologic Significance of Quaking Expression in Hepatocellular Carcinoma.
Kim SE; Park CK; Park JW; Lee JW; Choe JY; Cho YA
In Vivo; 2024; 38(4):2064-2073. PubMed ID: 38936929
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Dobrescu AE; Basa SN; Cornianu M; Lazăr DC; Suciu SC; Tudor A; Viţa OC; Tarţă-Marcu DC; Barna RA; Lazăr OF
Rom J Morphol Embryol; 2019; 60(4):1243-1251. PubMed ID: 32239101
[TBL] [Abstract][Full Text] [Related]
53. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection.
Zhang ZF; Feng XS; Chen H; Duan ZJ; Wang LX; Yang D; Liu PX; Zhang QP; Jin YL; Sun ZG; Liu H
BMC Gastroenterol; 2016 Jun; 16(1):57. PubMed ID: 27255554
[TBL] [Abstract][Full Text] [Related]
55. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
[TBL] [Abstract][Full Text] [Related]
56. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
[TBL] [Abstract][Full Text] [Related]
57. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.
Yao D; Peng S; Dai C
BMC Cancer; 2013 Sep; 13():432. PubMed ID: 24059685
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional repressor snail and metastasis in hepatocellular carcinoma.
Chen D; Zheng X; Jiao X; Gao Y; Zhang K; Liang J
Hepatogastroenterology; 2012; 59(117):1359-65. PubMed ID: 22107747
[TBL] [Abstract][Full Text] [Related]
59. The prognostic value of vascular endothelial growth factor in hepatocellular carcinoma for predicting metastasis after curative resection.
Minata M; Harada KH; Kudo M; Ikai I; Nishida N
Oncology; 2013; 84 Suppl 1():75-81. PubMed ID: 23428863
[TBL] [Abstract][Full Text] [Related]
60. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
